ANO1 and prostate cancer: Amplification or overexpression of ANO1 has been found in several cancers, including gastrointestinal stromal tumor (GIST), head and neck squamous cell carcinoma (HNSCC), prostate cancer, breast cancer and pancreatic cancer [11–17].